Skip to main content
PLOS One logoLink to PLOS One
. 2026 Sep 30;21(9):e0358798. doi: 10.1371/journal.pone.0358798

Complexity of hospital demand during the COVID-19 pandemic in Mexico City

Guillermo de Anda-Jáuregui 1,2,*, José Sifuentes-Osornio 3, Ofelia Angulo-Guerrero 4,5, Juan L Díaz-De-León-Santiago 4,5, Héctor Benítez-Pérez 6, Luis A Herrera 7,8, Oliva López-Arellano 9, Arturo Revuelta-Herrera 9, Ana R Rosales-Tapia 10, Manuel Suárez-Lastra 10, David Kershenobich 3,11, Rosaura Ruiz-Gutiérrez 4,5, Enrique Hernández-Lemus 1
Editor: Benedetto Schiavo12
PMCID: PMC13626320  PMID: 42814707

Abstract

The COVID-19 pandemic posed unprecedented challenges to healthcare systems worldwide. In densely populated urban areas such as Mexico City, hospital strain was amplified by high case volumes and limited resources. This study aims to characterize the spatial and temporal organization of hospital demand and its relationship to patient outcomes. We conducted a retrospective analysis of COVID-19 hospitalization data in Mexico City using line-list data from the SISVER surveillance system. Spatial dynamics were examined using the weighted centroid of hospitalizations, and patient–hospital interactions were modeled as a time-resolved bipartite network. The emergence of giant components was used as a proxy for system strain and evaluated in relation to patient outcomes. Hospital demand exhibited marked spatial shifts, including a northward displacement of the hospitalization centroid over time. A small group of 17 hospitals consistently managed the majority of cases. During periods of high demand, the network underwent structural transitions characterized by the emergence of large connected components spanning diverse neighborhoods. These periods of increased system-wide connectivity were associated with higher case fatality rates, particularly among patients over 40. Hospital demand reorganizes at the system level under stress, leading to loss of spatial structure and increased strain. The emergence of large connected components may serve as an early indicator of systemic overload. These findings provide a network-based perspective on healthcare system stress and may inform strategies for resource allocation and emergency response.

Introduction

The COVID-19 pandemic posed unprecedented challenges across all sectors of society. Beyond the personal toll, healthcare systems were pushed to their limits: major institutions exceeded capacity, medical staff were overwhelmed, and critical resources became scarce [1–3]. The scale of this disruption was quantified in a landmark comparative analysis of 32 countries, which documented more than 30 million missed hospitalizations and 4 million missed surgical procedures in 2020–2021 alone, with countries that had fewer baseline healthcare workers and hospital beds experiencing disproportionately greater disruptions [4]. The spatial and temporal patterns of these pressures revealed deep-seated structural constraints, insights that are crucial for preparing for future crises of similar magnitude [5–7]. Surge-capacity models developed early in the pandemic demonstrated that even well-resourced systems lacked adequate tools to anticipate the magnitude and duration of demand spikes, underscoring the need for dynamic, data-driven approaches to healthcare planning [8]. These challenges were especially complex in metropolitan areas, where large, heterogeneous populations amplified the scale and impact of the emergency. Mexico City exemplifies such a scenario.

Mexico City, home to the highest concentration of tertiary care hospitals in Mexico, provides healthcare services not only to its 9 million permanent residents but also to an additional 13 million people from the surrounding metropolitan area and beyond. Despite this extensive healthcare infrastructure, the COVID-19 pandemic imposed unprecedented strain on the system, challenging its capacity to meet the rapidly growing demand for medical attention.

This experience is not unique: across Latin America, a region where densely populated cities with concentrated poverty were disproportionately affected, socioeconomic inequities deepened the burden on urban healthcare networks [9,10]. Within Mexico City specifically, seroprevalence surveys estimated that nearly 20% of the population had been exposed to SARS-CoV-2 by early 2021 [10], and prior work has documented that the spatial distribution of cases strongly co-varied with social marginalization across boroughs and neighborhoods [11,12].

In this regard, the pandemic exposed the (already existent, but possibly latent) inherent complexities of the health system, which operates as a multifaceted organization with numerous interdependent components. Traditionally viewed as hierarchical and linear, health systems are now recognized as complex adaptive systems characterized by non-linear interactions, self-organization, and emergent behavior [11]. This conceptual framing has proven especially useful during the pandemic: research on healthcare systems under COVID-19 stress has shown that shocks of sufficient magnitude can exceed critical adaptation thresholds, triggering qualitative changes in system behavior analogous to phase transitions [13,14]. The sudden and unpredictable nature of the COVID-19 crisis [15] further amplified these complexities, revealing both the strengths and vulnerabilities of the healthcare network in Mexico City.

The present research systematically examines the evolving patterns of hospital demand during the pandemic, highlighting the dynamic shifts in patient behavior and hospital utilization. It was observed that, as the crisis intensified, individuals often sought care at hospitals far from their residences, resulting in an uneven and entangled distribution of demand across the city’s healthcare facilities. Similar patterns of non-proximity care-seeking behavior have been documented using network science approaches in other healthcare systems. Network science is an interdisciplinary approach to complex systems that embraces complex collective behavior by modeling the interactions using networks in which the members of the collective (termed nodes, can be humans, animals, pathogens, proteins, genes, and so on) interact with each other via links (that may represent co-existence, correlation, physical, chemical or biological interaction, etc.) giving rise to emergent phenomena [16]. Network science has been successfully applied to epidemic phenomena in the past [17–20]. Along similar lines, Kohler et al. modeled inpatient care as networks of clinical units and patients, revealing that topological features of the network could identify bottlenecks and dysfunctional states [21]. More recently, Zhong et al. analyzed patient flow networks built using electronic medical records across U.S. healthcare systems and showed that, during COVID-19, cross-regional patient flows increased and network absorptivity rose by approximately 10% over pre-pandemic baseline: a finding that illustrates how stressed systems redistribute demand in ways that are not easily predicted from local capacity alone [22]. Network-based approaches have also been proposed for planning capacity across hierarchical multi-facility systems during surges [23] and for real-time surveillance of nosocomial transmission chains [24]. While some hospitals experienced consistently high demand, others saw fluctuating levels of patient load, reflecting the adaptive and often chaotic nature of the pandemic response.

By analyzing these patterns, key factors were identified as contributors to the resilience of the health system, as well as areas where it struggled to cope with the extraordinary pressures of the pandemic. These patterns are analyzed at the level of the full system, focusing on how hospital demand reorganizes under stress and how such reorganization is associated with patient outcomes. These insights may become crucial for developing strategies to enhance the system’s preparedness and adaptability in future health emergencies.

In summary, this research introduces a network-based way to measure healthcare system stress by modeling patient-hospital interactions as a bipartite network, where the emergence of “giant components” (i.e., large, entangled subgraphs encompassing over half the network) serves as a mathematical proxy for systemic overload. By analyzing COVID-19 data from Mexico City, we demonstrate that these network transitions reflect a shift toward a disorganized state where patients travel nearly twice the “optimal” distance to seek care. Most critically, this structural strain was found to correlate with higher case fatality rates for patients over 40, suggesting that monitoring network connectivity could provide a vital early warning system for predicting clinical risk during public health emergencies.

Methods

Epidemiological data

For this study, data from the centralized database for COVID-19 case reporting system (SISVER) was used. SISVER (respiratory disease epidemiological surveillance system) was managed by the Mexican federal government. The dataset is a “line-list” format, with each row representing an individual case. It is important to note that all information in this database is collected exclusively from official public reporting institutions at the state or federal level.

As part of the Federal Health System, our institutions were granted access to the complete dataset, comprising 130 variables per case. For this analysis, the study focused on key variables relevant to the research objectives, including the patient’s ZIP code of residence, date of symptom onset, age, hospitalization status, and the medical unit where the patient received care.

This dataset contained detailed insights into the spatiotemporal patterns and dynamics of COVID-19 hospitalizations within the study population. Only cases meeting the following criteria were included: (i) confirmed COVID-19 cases, verified through PCR or antigen testing; (ii) cases recorded in medical units or testing sites located within Mexico City boundaries; (iii) patients with a reported residence in Mexico City; and (iv) cases collected up to epidemiological week 16 of 2022 that required hospitalization. A total of 122,933 hospitalized cases were included in the analysis.

The study was approved by the ethics and research committees of the Instituto Nacional de Medicina Genómica (approval codes CEI/1479/20 and CEI 2020/21).

Medical unit data

Data on medical units were obtained from the Catalog of Unique Keys for Medical Units (CLUES), a federal database providing information on medical units across Mexico. Using the geolocation data provided in this catalog, the road distance between each medical unit and the centroid of each ZIP code in Mexico City was calculated.

Evaluation of distance traveled for COVID-19 medical attention

The travel behavior of patients requiring hospitalization was obtained by calculating the (road) distance they traveled from their place of residence (approximated by the centroid of their ZIP code, using in-house road accessibility data from UNAM’s Geography Institute) to the medical unit where they received treatment. The weekly weighted average distance traveled was computed using the formula:

Weighted Average Distance = ∑cp,hncp,h dcp,h 

Where ncp,h is the number of patients from ZIP code cp in hospital h, dcp,h is the distance between the (centroid of) ZIP code cp and hospital h, and n is the total number of patients requiring hospitalization in a given week. We compared this empirical distance to an ideal distance scenario, in which all patients received care at the medical unit closest to their residence; in this scenario, each patient is assigned to the geographically closest hospital according to the same distance metric, without considering capacity constraints.

Hospital territorial demand network model

To capture the complexity of hospital demand dynamics throughout the pandemic, a series of weighted bipartite networks representing the relationships between ZIP codes (residential areas) and hospitals were constructed. For each week, a network with ZIP codes cp and hospitals h as nodes, connected by edges when at least one resident of ZIP code cp was treated at hospital h was created. The weight of each edge represented the number of patients from that ZIP code treated at the hospital.

Formally, each bipartite network B can be defined as

Bt(CP,H, W) 

where CP is the set of ZIP codes for the Mexico City Metropolitan Area, H is the set of hospitals providing COVID-19 treatment, and W is the set of patients from a given ZIP code treated at a given hospital. An edge in the network exists if Wcp,h > 0; that is, if at least one resident of a given ZIP code was treated in a given hospital, in the time period (week) represented by that particular network.

This analysis focused on the largest connected component (LCC) of the network. A connected component of a network is a subset of nodes that may reach each other through a path of edges in the network. With this in mind, the largest connected component of a network is the component containing the most nodes out of all the components in the network. Formally,

LCC(B) =maxCi∈C(B)|V(Ci)|

Where C(B) is the set of connected components. The largest connected component will therefore contain the maximum number of nodes in the network, compared to all other components.

Following this, the existence of a giant component can be formally defined as

LCC(B) = GC(B) iff |V(LCC(B)) ≥ V(B)2+1

That is, the largest connected component of a network is considered giant if it contains more than half the total number of nodes in the network.

The emergence of such giant components over time, which indicate a phase transition in the network structure, was monitored. These transitions reflect changes in hospital demand patterns, especially during the progression of the pandemic and hospital system strain (in terms of demand and capacity saturation). All network analyses were performed using Igraph version 2.2 [25] for R (version 4.5).

Results and discussion

Hospital demand is a spatially dynamic variable that changes throughout the pandemic

The COVID-19 pandemic in Mexico City presented a complex and evolving landscape of hospital demand. Contrary to the assumption that certain areas would bear a consistent burden of cases, the spatial distribution of hospitalizations shifted notably over time, often in counterintuitive ways [26]. This dynamic movement of cases reflects the heterogeneous patterns of exposure and vulnerability across different neighborhoods of the city, as well as structural biases in social development between boroughs and neighborhoods [27,28].

During the initial stages of the pandemic, cases were heavily concentrated in certain areas, primarily those with higher population density and relatively lower socioeconomic status [29]. However, as the pandemic evolved, the geographical footprint of the virus expanded, reaching new regions drastically altering the patterns of hospital demand. This dispersion of cases is indicative of varied levels of exposure across the city, influenced by factors such as population mobility, compliance with public health measures, and local transmission dynamics [12].

To capture these shifts in hospital demand, the weighted centroid of hospitalizations over time was measured, as seen in Fig 1. This metric was useful to quantify the “center of mass” of hospital demand, weighted by the number of cases in each location. This analysis revealed a gradual but significant northward movement of the centroid as the pandemic progressed. Initially, demand was focused in the densely populated southern and eastern boroughs of Mexico City. Over time, however, this centroid shifted towards the northern regions, highlighting the spatially dynamic nature of the pandemic.

Fig 1. Spatial trajectory of the weighted centroid of COVID-19 hospitalizations in Mexico City over time, calculated based on patients’ place of residence (ZIP code level).

Fig 1

The centroid represents the center of mass of hospitalization demand at each epidemiological week. Red markers indicate hospitals designated for COVID-19 care. Panel A shows the full city extent; Panel B provides a zoomed view of the centroid trajectory.

This northward drift in hospital demand underscores the adaptability of the healthcare system, which had to reallocate resources and adjust strategies in response to the changing geographical distribution of cases. Understanding these spatial dynamics is crucial for optimizing resource allocation and ensuring that all areas of the city have adequate access to medical care, particularly during periods of high demand.

Nevertheless, hospitalizations were concentrated in a few hospitals throughout the pandemic

Despite the dynamic distribution of COVID-19 cases across Mexico City, the majority of hospitalizations were concentrated in a relatively small number of medical facilities. Specifically, 17 hospitals were ranked in the top 10 in terms of admissions for at least 35 weeks, as seen in Fig 2. These hospitals, spanning various sectors of the healthcare system (including the Mexican Social Security Institute (IMSS), the Institute for Social Security and Services for State Workers (ISSSTE), the Health Secretary, and the military), handled most of the hospital demand throughout the pandemic [26].

Fig 2. Distribution of COVID-19 hospitalizations across medical units in Mexico City.

Fig 2

Bars represent the total number of hospitalized cases treated by each hospital over the study period. The inset map shows the geographic location of the hospitals most consistently ranked among the highest in patient volume.

The consolidation of hospitalizations in these facilities reflects a multifactorial process shaped by population distribution, healthcare system structure, and resource allocation. Understanding how these hospitals came to dominate the demand landscape during different phases of the pandemic can offer valuable insights for optimizing resource distribution in future public health emergencies. For a population as socioeconomically and geographically disparate as Mexico City, comparing the evolution of these facilities’ demand with the locations of the most affected populations highlights key patterns in access to care and resource utilization.

A distinction exists between hospitals under the Federal Health Secretary, local healthcare services of Mexico City, and those belonging to IMSS and ISSSTE. IMSS and ISSSTE hospitals regularly serve enrolled beneficiaries, while federal and local hospitals absorb a more heterogeneous patient population. Nevertheless, during the pandemic those institutions were instructed to provide services to the general population. However, there is currently no available data that quantitatively shows how this affected access to health services. Such data may provide better insights on resource allocation.

These hospitals experienced varying levels of demand over time, with most seeing significant increases during the high-contagion waves of the B.1.519 variant [30], the Delta variant, and, to a lesser extent, the first Omicron wave [31]; as seen in Fig 3. Demand waned, but did not disappear, as vaccination efforts advanced and reinfections came to dominate the epidemiological landscape [32]. During the initial phase of the pandemic, the military hospital managed a substantial portion of the hospitalizations. In subsequent waves, the special COVID-19 temporal unit, established as a dedicated response facility in a large convention center in the northwestern part of the city, absorbed the majority of hospitalizations, particularly during the B.1.519 wave. This temporary unit represented an instance of adaptability within the otherwise static hospital infrastructure.

Fig 3. Weekly time series of COVID-19 hospitalizations in the hospitals most consistently ranked among the highest in patient volume in Mexico City.

Fig 3

Values represent the number of new hospital admissions per week over the study period.

Hospital attention seeking behavior did not limit itself by spatial closeness

To understand the hospital attention-seeking behavior of COVID-19 patients in Mexico City, the distance patients traveled from their place of residence to the hospital where they received care was analyzed. The analysis focused on the weekly average distance traveled, calculated from the centroid of each patient’s ZIP code to the hospital where they were treated. This distance was then compared to an “optimal” scenario, in which patients would have been treated at the hospital closest to their residence. Fig 4 highlights these results.

Fig 4. Weekly time series of the weighted average distance (km) traveled by COVID-19 hospitalized patients from their place of residence (ZIP code centroid) to the treating hospital in Mexico City.

Fig 4

The upper panel shows empirical distances; the lower panel shows the optimal distance: assuming admission to the nearest hospital. Dotted lines indicate transitions in the epidemiological stoplight system over the study period.

The analysis revealed that the actual distance traveled by patients was nearly twice as long as the optimal distance throughout the pandemic. This discrepancy indicates that patients did not necessarily seek care at the nearest facility, even when geographical proximity would suggest otherwise. Instead, their hospital-seeking behavior was influenced by other factors, perhaps including perceived quality of care, hospital reputation, and possibly the availability of specialized services.

Moreover, the actual distance traveled by patients increased significantly during periods of high hospital saturation, such as during the peak waves of the pandemic, and following the relaxation of public health measures, such as the change in the epidemiological stoplight from red to orange. These patterns suggest that when hospital resources were strained or when restrictions were eased, patients were more likely to travel farther to seek care, possibly due to overcrowding at closer facilities or increased mobility.

The analysis of these travel patterns highlights the constraints that prevented the healthcare system from evenly distributing hospital demand, as well as the behavioral flexibility of patients in seeking medical attention. It also underscores the need for strategies to reduce these travel burdens, such as improving resource allocation and communication to ensure that patients are aware of available care options closer to home, particularly during periods of high hospital demand.

It should be noted that hospital demand fluctuated in a closely correlated way for both general hospitalization and intensive care units (ICU). This is important as it highlights the level of stress and participation of each institution facing the pandemic. In general, it is expected that a higher demand of ICU beds would be indicative of a stronger impact on resource demands. As shown in Fig 5, ICU demand scaled in considerably the same proportion throughout the first four waves. Only after vaccination efforts were widely deployed did the ICU demand decrease, as seen in the fifth wave.

Fig 5. Comparison of hospital demand in Mexico City, measured as daily COVID-19 admissions to general hospitalization beds and intensive care unit (UCI, unidad de cuidado intensivo in spanish) beds over the study period.

Fig 5

Values represent the number of new admissions per day in each category.

Higher hospital demand leads to phase transition in the hospital demand network

To better understand the dynamics of hospital demand during the COVID-19 pandemic, the interaction between hospital demand and supply via a “hospital demand network” was modeled. This network is represented as a bipartite graph, where nodes are either residential areas (defined by ZIP codes) or hospitals, and connections are established when a hospital provides care to patients from a given area. The structure of this network evolves over time, as seen in Fig 6, reflecting changes in patient behavior and hospital utilization.

Fig 6. Weekly time series of the relative size of the largest connected component (LCC) in the hospital demand network, expressed as the percentage of nodes included in the LCC.

Fig 6

Panels correspond to different age groups. Dotted lines indicate transitions in the epidemiological stoplight system over the study period.

A key feature of this network is the emergence of giant components: connected subgraphs encompassing more than 50% of the nodes in the network. These giant components are indicative of a phase transition [33,34] in the hospital demand network, a phenomenon that occurs as the system transitions from a more ordered to a more disordered state [35] in response to increased demand.

During periods of lower hospital demand, the network is more structured and ordered, with patients predominantly seeking care at hospitals located closer (although not necessarily the nearest) to their place of residence. This results in a network composed of many small, distinct components, where a small set of hospitals serve a specific set of neighborhoods. However, as demand increases, this orderly structure breaks down. Patients from various areas begin to seek care at hospitals outside their immediate vicinity, either due to overcrowding or the unavailability of care at closer facilities.

This shift leads to the formation of a giant component in the network, characterized by hospitals admitting patients from a wide range of neighborhoods. The network becomes more disordered, reflecting the strain on the healthcare system and the loss of spatial constraints on patient behavior. This phase transition is a critical indicator of system overload and occurs just before or during periods of high hospital demand, such as during peak waves of the pandemic.

The emergence of giant components in the hospital demand network highlights the nonlinear dynamics of the healthcare system under stress. Understanding these transitions can provide valuable insights into the capacity limits of the system and the points at which patient care becomes increasingly disorganized. This knowledge is crucial for designing interventions aimed at mitigating the impact of surges in hospital demand and maintaining a more stable and effective healthcare network during future public health crises.

Higher stress in the hospital network leads to higher risk for hospitalized patients

Using the largest connected component (LCC) in the hospital demand network as a measure of “disordered strain” on the healthcare system, an increased strain, indicative of higher hospital demand, was associated with less favorable outcomes for hospitalized patients. As the LCC expands, encompassing a larger portion of the network, it reflects a breakdown in the structured distribution of patients across hospitals, suggesting that hospitals are increasingly overwhelmed and are treating patients from a broader range of neighborhoods.

This relationship between network strain and patient outcomes varied by age group; as seen in Fig 7. This association was particularly pronounced among older patients, for whom age is already established as a primary risk factor for severe COVID-19 outcomes [36]. In these older age groups, the correlation between increased network strain and adverse outcomes was not linear. Instead, it exhibited a phase transition: as the size of the giant component in the network grew, there was a marked increase in risk for hospitalized patients, particularly those over the age of 40. This is in agreement with what previous research had shown, particularly regarding non-comorbid patients [37].

Fig 7. Association between hospital case fatality rate and the relative size of the largest connected component (LCC) in the hospital demand network.

Fig 7

Each point represents an observation at a given time period. The LCC size is expressed as the percentage of nodes included in the component. Blue lines show LOESS regression fits. Panels correspond to different age groups.

This phase transition in risk suggests that the LCC, as a global measure of network strain, may be capturing the cumulative effects of increased pressure on individual hospitals. During periods of high demand, hospitals experience a higher patient load, potentially leading to resource shortages, longer wait times, and diminished quality of care: all of which can contribute to worse outcomes for patients, as reported in comparisons of temporary ICUs units with conventional ICUs [38] and in studies of poor ICU bed availability [39]. The non-linear nature of this relationship underscores the complexity of the healthcare system, where local interactions and constraints can lead to emergent global phenomena that significantly impact patient care.

Understanding this dynamic is crucial for managing hospital resources and mitigating risk during periods of high demand. It highlights the need for interventions that not only address hospital capacity at a local level but also consider the broader network effects that can exacerbate strain across the healthcare system. Recognizing and responding to these critical phase transitions could be key to improving patient outcomes in future public health emergencies.

Conclusions

The COVID-19 pandemic in Mexico City illustrates the complex and dynamic nature of public health crises, driven by multiple interacting layers: epidemic spread, social behavior, and systemic constraints. The crisis demanded a multifaceted response, and adaptive measures, such as temporary COVID-19 care units, proved effective in absorbing sudden surges in hospital demand. Facilities like the one established in the city’s northwest played a crucial role during peak periods and offer a valuable blueprint for future emergency deployments.

The usefulness of these interventions underscores the need to institutionalize rapid-response strategies that enhance system flexibility and resilience. Expanding the capacity to deploy temporary medical facilities, alongside more agile resource allocation models, can help mitigate future shocks to healthcare infrastructure.

Additionally, incorporating complexity science approaches, such as network analysis of hospital demand, offers powerful early warning tools. These methods can detect critical transitions and emerging strains, enabling timely, targeted responses. Embedding such tools into public health planning will be key to anticipating and managing the challenges of future health emergencies.

Acknowledgments

The authors thank the Mexico City Ministry of Health and the National Epidemiological Surveillance System (SISVER) for data access and logistical support.

Data Availability

All relevant data for this study are publicly available from the GitHub repository (https://github.com/guillermodeandajauregui/c19hospitals_public).

Funding Statement

This project was partially funded by CONACYT Project 320557 (to GA-J). Sponsors did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Sachs JD, Karim SSA, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022;400(10359):1224–80. doi: 10.1016/S0140-6736(22)01585-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Anderson M, Pitchforth E, Asaria M, Brayne C, Casadei B, Charlesworth A, et al. LSE-Lancet Commission on the future of the NHS: Re-laying the foundations for an equitable and efficient health and care service after COVID-19. Lancet Lond Engl. 2021;397(10288):1915–78. doi: 10.1016/S0140-6736(21)00232-4 [DOI] [PubMed] [Google Scholar]
  • 3.Panneer S, Kantamaneni K, Palaniswamy U, Bhat L, Pushparaj RRB, Nayar KR, et al. Health, economic and social development challenges of the COVID-19 pandemic: strategies for multiple and interconnected issues. Healthc Basel Switz. 2022;10(5):770. doi: 10.3390/healthcare10050770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ledesma JR, Chrysanthopoulou SA, Lurie MN, Nuzzo JB, Papanicolas I. Health system resilience during the COVID-19 pandemic: A comparative analysis of disruptions in care from 32 countries. Health Serv Res. 2024;59(6):e14382. doi: 10.1111/1475-6773.14382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Huang R, Liu M, Ding Y. Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis. J Infect Dev Ctries. 2020;14(3):246–53. doi: 10.3855/jidc.12585 [DOI] [PubMed] [Google Scholar]
  • 6.Li A, Zhao P, Haitao H, Mansourian A, Axhausen KW. How did micro-mobility change in response to COVID-19 pandemic? A case study based on spatial-temporal-semantic analytics. Comput Environ Urban Syst. 2021;90:101703. doi: 10.1016/j.compenvurbsys.2021.101703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wu X, Zhang J. Exploration of spatial-temporal varying impacts on COVID-19 cumulative case in Texas using geographically weighted regression (GWR). Environ Sci Pollut Res Int. 2021;28(32):43732–46. doi: 10.1007/s11356-021-13653-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Klein MG, Cheng CJ, Lii E, Mao K, Mesbahi H, Zhu T, et al. COVID-19 Models for Hospital Surge Capacity Planning: A Systematic Review. Disaster Med Public Health Prep. 2022;16(1):390–7. doi: 10.1017/dmp.2020.332 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Economic Commission for Latin America and the Caribbean ECLAC. The sociodemographic impacts of the COVID-19 pandemic in Latin America and the Caribbean. Santiago: ECLAC. 2022. https://hdl.handle.net/11362/47923 [Google Scholar]
  • 10.Poirier MJ, Morales Caceres C, Dykstra TE, Dayrell Ferreira Sales A, Caiaffa WT. Social epidemiology of urban COVID-19 inequalities in Latin America and Canada. Int J Equity Health. 2024;23(1):212. doi: 10.1186/s12939-024-02301-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hernandez-Lemus E, Martinez-García M. Health Systems as Complex Systems. Am J Oper Res. 2013;3(1A):113–26. doi: 10.4236/ajor.2013.31A011 [DOI] [Google Scholar]
  • 12.de Anda-Jáuregui G, García-García L, Hernández-Lemus E. Modular reactivation of Mexico City after COVID-19 lockdown. BMC Public Health. 2022;22(1):961. doi: 10.1186/s12889-022-13183-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Stevens JP, O’Donoghue A, Horng S, Tandon M, Tabb K. Healthcare’s earthquake: lessons from complex adaptive systems to develop Covid-19-responsive measures and models. Catal Non-Issue Content. 2020;1(5). doi: 10.1056/CAT.20.0505 [DOI] [Google Scholar]
  • 14.Angeler DG, Eyre HA, Berk M, Allen CR, Hynes W, Linkov I. Adaptation, transformation and resilience in healthcare comment on “Government actions and their relation to resilience in healthcare during the COVID-19 pandemic in New South Wales, Australia and Ontario, Canada.”. Int J Health Policy Manag. 2022. doi: 10.34172/ijhpm.2022.7043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jones A, Strigul N. Is spread of COVID-19 a chaotic epidemic?. Chaos Solitons Fractals. 2021;142:110376. doi: 10.1016/j.chaos.2020.110376 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Barabási AL, Pósfai M. Network science. Cambridge, United Kingdom: Cambridge University Press. 2016. [Google Scholar]
  • 17.Pastor-Satorras R, Vespignani A. Epidemic spreading in scale-free networks. Phys Rev Lett. 2001;86(14):3200–3. doi: 10.1103/PhysRevLett.86.3200 [DOI] [PubMed] [Google Scholar]
  • 18.Pastor-Satorras R, Castellano C, Van Mieghem P, Vespignani A. Epidemic processes in complex networks. Rev Mod Phys. 2015;87(3):925–79. doi: 10.1103/RevModPhys.87.925 [DOI] [Google Scholar]
  • 19.Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395–400. doi: 10.1126/science.aba9757 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kraemer MUG, Yang C-H, Gutierrez B, Wu C-H, Klein B, Pigott DM, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493–7. doi: 10.1126/science.abb4218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kohler K, Jankowski MD, Bashford T, Goyal DG, Habermann EB, Walker LE. Using network analysis to model the effects of the SARS Cov2 pandemic on acute patient care within a healthcare system. Sci Rep. 2022;12(1):10050. doi: 10.1038/s41598-022-14261-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhong L, Rennert L, Pei S, Gao J. Enhancing structural resilience in healthcare through patient flow network. 2025. 10.48550/arXiv.2410.06031 [DOI]
  • 23.Shoaib M, Mustafee N, Madan K, Ramamohan V. Leveraging multi-tier healthcare facility network simulations for capacity planning in a pandemic. Socioecon Plann Sci. 2023;101660. doi: 10.1016/j.seps.2023.101660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Price JR, Mookerjee S, Dyakova E, Myall A, Leung W, Weiße AY, et al. Development and delivery of a real-time hospital-onset COVID-19 surveillance system using network analysis. Clin Infect Dis. 2021;72(1):82–9. doi: 10.1093/cid/ciaa892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Antonov M, Csárdi G, Horvát S, Müller K, Nepusz T, Noom D. igraph enables fast and robust network analysis across programming languages. arXiv. 2023. 10.48550/ARXIV.2311.10260 [DOI] [PMC free article] [PubMed]
  • 26.Galindo-Pérez MC, Suárez M, Rosales-Tapia AR, Sifuentes-Osornio J, Angulo-Guerrero O, Benítez-Pérez H. Territorial strategy of medical units for addressing the first wave of the COVID-19 pandemic in the metropolitan area of Mexico City: analysis of mobility, accessibility and marginalization. International J Environ Res Public Health. 2022;19(2):665. doi: 10.3390/ijerph19020665 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.de Anda-Jáuregui G, Guzmán P, Fontanelli O, Meneses A, Hernández A, de Anda-Gil J, et al. The Contact and Mobility Networks of Mexico City. ArXiv200714596 Phys [Internet]. 2021; [cited 2021 Dec 10]. Available from: http://arxiv.org/abs/2007.14596
  • 28.Klein B, Hartle H, Shrestha M, Zenteno AC, Barros Sierra Cordera D, Nicolás-Carlock JR, et al. Spatial scales of COVID-19 transmission in Mexico. PNAS Nexus. 2024;3(9):pgae306. doi: 10.1093/pnasnexus/pgae306 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Molina-Torres R, Nolasco-Jáuregui O, Rodriguez-Torres EE, Itzá-Ortiz BA, Quezada-Téllez LA. A comparative analysis of urban development, economic level, and COVID-19 cases in Mexico City. J Urban Management. 2021;10(3):265–74. doi: 10.1016/j.jum.2021.06.007 [DOI] [Google Scholar]
  • 30.Cedro-Tanda A, Gómez-Romero L, Alcaraz N, de Anda-Jauregui G, Peñaloza F, Moreno B. The evolutionary landscape of SARS-CoV-2 variant B.1.1.519 and its clinical impact in Mexico City. Viruses. 2021;13(11):2182. doi: 10.3390/v13112182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cedro-Tanda A, Gómez-Romero L, de Anda-Jauregui G, Garnica-López D, Alfaro-Mora Y, Sánchez-Xochipa S, et al. Early genomic, epidemiological, and clinical description of the SARS-CoV-2 omicron variant in Mexico City. Viruses. 2022;14(3):545. doi: 10.3390/v14030545 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.de Anda-Jáuregui G, Gómez-Romero L, Cañas S, Campos-Romero A, Alcántar-Fernández J, Cedro-Tanda A. COVID-19 reinfections in Mexico City: Implications for public health. Front Public Health. 2024;11:1321283. doi: 10.3389/fpubh.2023.1321283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vicsek T. Phase transitions and overlapping modules in complex networks. Physica A: Statistical Mechanics and its Applications. 2007;378(1):20–32. doi: 10.1016/j.physa.2006.11.075 [DOI] [Google Scholar]
  • 34.Liu X, Pan L, Stanley HE, Gao J. Multiple phase transitions in networks of directed networks. Phys Rev E. 2019;99(1–1):012312. doi: 10.1103/PhysRevE.99.012312 [DOI] [PubMed] [Google Scholar]
  • 35.Hu Y, Ksherim B, Cohen R, Havlin S. Percolation in interdependent and interconnected networks: Abrupt change from second- to first-order transitions. Phys Rev E Stat Nonlin Soft Matter Phys. 2011;84(6 Pt 2):066116. doi: 10.1103/PhysRevE.84.066116 [DOI] [PubMed] [Google Scholar]
  • 36.Sifuentes-Osornio J, Angulo-Guerrero O, De Anda-Jáuregui G, Díaz-De-León-Santiago JL, Hernández-Lemus E, Benítez-Pérez H. Probability of hospitalisation and death among COVID-19 patients with comorbidity during outbreaks occurring in Mexico City. J Glob Health. 2022;12:05038. doi: 10.7189/jogh.12.05038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Martínez-Guerra BA, Medrano-Borromeo C, González-Lara MF, Román-Montes CM, Tamez-Torres KM, Rajme-López S, et al. Predictors of poor outcomes in young non-comorbid patients with COVID-19. Rev Invest Clin. 2022;74(5):268–75. doi: 10.24875/RIC.22000162 [DOI] [PubMed] [Google Scholar]
  • 38.Jimenez JV, Olivas-Martinez A, Rios-Olais FA, Ayala-Aguillón F, Gil-López F, Leal-Villarreal MADJ, et al. Outcomes in temporary ICUs versus conventional ICUs: An observational cohort of mechanically ventilated patients with COVID-19-induced acute respiratory distress syndrome. Crit Care Explor. 2022;4(4):e0668. doi: 10.1097/CCE.0000000000000668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, Lozano-Cruz OA, Ortiz-Brizuela E, Tovar-Méndez VH, et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; Causes of death, risk factors and the impact of hospital saturation. PLoS One. 2021;16(2):e0245772. doi: 10.1371/journal.pone.0245772 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Benedetto Schiavo

16 Mar 2026

PLOS One

Dear Dr. de Anda-Jáuregui,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The topic addressed in your study is relevant and potentially of interest to the readership. However, before the manuscript can be sent for external peer review, several issues need to be addressed.

First, the manuscript should be reorganized to fully comply with the journal’s submission guidelines (https://journals.plos.org/plosone/s/submission-guidelines#loc-manuscript-organization). In particular, the structure of the manuscript should follow the standard format required by PLOS ONE, as indicated in the submission instructions.

Second, in our opinion the Introduction requires further development. Given the large body of international literature on COVID-19 hospital demand, health-system stress, and network-based approaches, the state of the art should be strengthened. We encourage the authors to better contextualize their work within recent international studies and to clearly articulate the specific novelty and contribution of the present study relative to existing publications.

In addition, please consider addressing the following points before resubmission:

  • The methodological description should be clarified, particularly regarding the construction of the bipartite network and the definition and interpretation of the largest connected component as an indicator of system strain.

  • The manuscript would benefit from language editing and stylistic improvements, including reducing the excessive use of em-dashes (—) within sentences, which in several cases interrupts the flow of the text (e.g., “Adaptive measures—such as the deployment of temporary COVID-19 units—proved effective…”).

  • Please ensure that all figures are fully interpretable as standalone elements, with clearer captions explaining variables, temporal coverage, and analytical assumptions.

Once these issues are satisfactorily resolved, the manuscript will be reconsidered for peer review.

Please submit your revised manuscript by Apr 30 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Benedetto Schiavo, Ph.D.

Academic Editor

PLOS One

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure:

“CONACYT Grant to Guillermo de Anda Jáuregui”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors thank the Mexico City Ministry of Health and the National Epidemiological Surveillance System (SISVER) for data access and logistical support. This work was partially supported by CONACYT project 320557 (to GA-J).”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“CONACYT Grant to Guillermo de Anda Jáuregui”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5.  We note that Figures 1 and 2 in your submission contain map/satellite images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figures 1 and 2 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Sep 30;21(9):e0358798. doi: 10.1371/journal.pone.0358798.r002

Author response to Decision Letter 1


22 Apr 2026

Response to reviewer:

First, the manuscript should be reorganized to fully comply with the journal’s submission guidelines. In particular, the structure of the manuscript should follow the standard format required by PLOS ONE, as indicated in the submission instructions.

We thank the reviewer for their helpful comments. We have reorganized the manuscript to follow the standard format used in PLOS ONE. We decided on keeping the section of “results and discussion” in its combined form, as we find that it makes more sense for the narrative flow. Considering that other manuscripts in PLOS ONE do have such combined results and discussion sections, we believe that this does fit the format of the journal.

Second, in our opinion the Introduction requires further development. Given the large body of international literature on COVID-19 hospital demand, health-system stress, and network-based approaches, the state of the art should be strengthened. We encourage the authors to better contextualize their work within recent international studies and to clearly articulate the specific novelty and contribution of the present study relative to existing publications.

We thank the reviewer for this comment. In response, we have strengthened the Introduction by incorporating additional international literature on COVID-19 hospital demand, health-system stress, and network-based approaches, and by clarifying the specific contribution of our work.

First, to contextualize our study within the broader international literature on health-system stress and disruption during COVID-19, we incorporated large-scale comparative and systems-level analyses (References 1-4), as well as studies addressing spatial and temporal dynamics of the pandemic (References 5-7) and hospital surge capacity (Ref. 8). These additions situate our work within established efforts to understand healthcare system strain under pandemic conditions.

Second, we expanded the discussion of health systems as complex adaptive systems by including references that explicitly frame healthcare under stress in terms of non-linear dynamics and phase transitions (References 11, 13, 14). This provides the conceptual basis for interpreting systemic responses to demand shocks.

Third, we strengthened the network-science component of the Introduction by incorporating foundational literature (Reference 16) and prior applications of network approaches to epidemic processes (References. 17-20), as well as recent studies specifically modeling healthcare systems and patient flows as networks (References. 21-24). These references position our work within existing network-based analyses of healthcare demand and system organization.

Finally, we clarified the novelty and contribution of the present study by explicitly framing hospital demand as a time-resolved bipartite network linking residential areas and healthcare facilities, and by focusing on the emergence of large connected components as indicators of system-wide reorganization under stress. Unlike prior studies, which have primarily examined spatial patterns, mobility, or patient flows in isolation, our approach integrates these elements into a unified network framework and directly relates changes in this system representation to patient outcomes.

The methodological description should be clarified, particularly regarding the construction of the bipartite network and the definition and interpretation of the largest connected component as an indicator of system strain.

We have modified the methods section to formally define both the bipartite network model used in this work, as well as the definition of largest and giant connected components for a general audience. We have clarified in this section that strain is referring to hospitalization demand. The larger interpretation of the relationship between network structure and this hospital demand, as well as the impact on outcomes, is covered in the results and discussion section.

The manuscript would benefit from language editing and stylistic improvements, including reducing the excessive use of em-dashes (—) within sentences, which in several cases interrupts the flow of the text (e.g., “Adaptive measures—such as the deployment of temporary COVID-19 units—proved effective…”).

We have modified the general writing of the manuscript to simplify the reading flow. We have reduced the use of em-dashes, as well as avoided the overuse of parenthetical phrases.

Please ensure that all figures are fully interpretable as standalone elements, with clearer captions explaining variables, temporal coverage, and analytical assumptions.

We have modified all captions to be self-contained and describe all variables needed for their interpretation.

We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

Done.

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Done.

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. Please remove any funding-related text from the manuscript, and ensure that this information is included only in the Funding Statement section of the submission form.

Done.

We note that Figures 1 and 2 in your submission contain map/satellite images which may be copyrighted. In order for us to publish this paper, we need to ensure that these images are not subject to copyright restrictions. We cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software, or copied from other publications. Please ensure that the maps used in your figures are either original, based on open data, or appropriately licensed, and provide the source of the map data in the figure captions.

These maps were generated by ourselves using open data and open source software. The geometries (shapefiles) for map generation were obtained from the mexican National Institute of Statistics and Geography (INEGI), using a cartography that is free and open. The actual visualizations were generated by ourselves using Rspatial packages. We have included the information of the INEGI shapefiles in the manuscripts to avoid giving the impression that maps were generated with proprietary data.

We thank the reviewer for their comments and suggestions, which surely improve the quality of our manuscript.

Please include the following items when submitting your revised manuscript:

A letter that responds to each point raised by the editor and reviewer(s).

A marked-up copy of your manuscript that highlights changes made to the original version.

An unmarked version of your revised manuscript.

We have included the requested items.

Attachment

Submitted filename: Response to reviewer - PLOS complexity hospitalization.docx

pone.0358798.s001.docx (9.5KB, docx)

Decision Letter 1

Benedetto Schiavo

1 Jun 2026

Dear Dr. de Anda-Jáuregui,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has improved substantially and, in my opinion, is now suitable for publication. Before final acceptance, I kindly ask the authors to address the minor issues listed below, carefully proofread the manuscript for any remaining typographical or grammatical errors, and ensure that page numbers are included in the revised version.

Please submit your revised manuscript by Jul 16 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only  the individual author can complete the verification step; PLOS staff cannot  verify ORCID iDs on behalf of authors.

We look forward to receiving your revised manuscript.

Kind regards,

Benedetto Schiavo, Ph.D.

Academic Editor

PLOS One

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: (No Response)

**********

Reviewer #1: Dear authors,

according to my assessment you have addressed all comments raised in the previous review round and have documented your revisions in detail using track changes. I agree that the “Results and Discussion” sections can be combined into a single chapter.

There are still a few minor spelling and grammar errors (few examples below), so I recommend reading through the manuscript carefully one more time.

p12 (Introduction)

he scale of this ... => The scale of this

p 15

According to the formulas 'largest connected component (LCC)' and 'giant component' are identical, is this correct?

All network analyses were performed using {igraph} version 2.2 (25) for R (version 4.5). => Igraph

p20

ICU´s => ICUs

Please insert page numbers.

**********

what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review?  For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

PLoS One. 2026 Sep 30;21(9):e0358798. doi: 10.1371/journal.pone.0358798.r004

Author response to Decision Letter 2


3 Sep 2026

Response to reviewers:

Reviewer comment: “p12 (Introduction) he scale of this ... => The scale of this”

Response: All located typos such as this have been addressed.

Reviewer comment: “According to the formulas ‘largest connected component (LCC)’ and ‘giant component’ are identical, is this correct?”

Response: We have modified the Methods section to address this question. The largest connected component is now correctly defined as the connected component containing the greatest number of nodes. A giant component is defined as the LCC only when its relative size exceeds one half of the nodes in the network. Thus, every weekly network has an LCC, but only some weeks exhibit a giant component.

Reviewer comment: “All network analyses were performed using {igraph} version 2.2 (25) for R (version 4.5). => Igraph”

Response: We have reformatted the reference as suggested.

Reviewer comment: “p20 ICU´s => ICUs”

Response: Corrected throughout the manuscript. We also replaced the Spanish acronym “UCI” with “ICU/ICUs” where appropriate.

Reviewer comment: “Please insert page numbers.”

Response: Page numbers have been inserted in the footer of the revised manuscript.

Reviewer comment: “There are still a few minor spelling and grammar errors... read through the manuscript carefully one more time.”

Response: We performed an additional proofreading pass and corrected minor spelling, punctuation, spacing, and grammar issues in the Introduction, Methods, Results and Discussion, and Conclusions sections.

Attachment

Submitted filename: Response_to_Reviewers_PONE-D-26-08590R1_m.docx

pone.0358798.s002.docx (20.2KB, docx)

Decision Letter 2

Benedetto Schiavo

6 Sep 2026

Complexity of hospital demand during the COVID-19 pandemic in Mexico City

PONE-D-26-08590R2

Dear Dr. de Anda-Jáuregui,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Benedetto Schiavo, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Benedetto Schiavo

PONE-D-26-08590R2

PLOS One

Dear Dr. de Anda-Jáuregui,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS One and supporting open access.

Kind regards,

PLOS One Editorial Office Staff

on behalf of

Dr. Benedetto Schiavo

Academic Editor

PLOS One

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewer - PLOS complexity hospitalization.docx

    pone.0358798.s001.docx (9.5KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewers_PONE-D-26-08590R1_m.docx

    pone.0358798.s002.docx (20.2KB, docx)

    Data Availability Statement

    All relevant data for this study are publicly available from the GitHub repository (https://github.com/guillermodeandajauregui/c19hospitals_public).


    Articles from PLOS One are provided here courtesy of PLOS

    RESOURCES